Federal update: DOJ partially rescheduled medical cannabis to Schedule III (April 28, 2026 final order). State-licensed medical operators may apply for expedited DEA registration through June 27, 2026; DEA hearing on full rescheduling set for June 29, 2026.

The Pill-Mill Era — 76 Billion Pills and the $26 Billion Settlement

Federal Drug Enforcement Administration ARCOS data unsealed in the Multi-District Litigation showed wholesalers shipped 76 billion oxycodone and hydrocodone pills across the United States between 2006 and 2014. West Virginia ranked among the most saturated jurisdictions per capita. Williamson, WV (population then ~3,000) received 21 million hydrocodone tablets at a single pharmacy over roughly a decade. National opioid-settlement recoveries since exceed $26 billion; West Virginia’s share, led by then-AG Patrick Morrisey, exceeds $1 billion.

Last verified: May 2026

The 76-Billion-Pill ARCOS Disclosure

In July 2019, after a years-long Washington Post and HD Media (the Charleston Gazette-Mail’s parent) FOIA-and-court fight, U.S. District Judge Dan Polster of the Northern District of Ohio — presiding over the federal opioid Multi-District Litigation (MDL 2804) — ordered the unsealing of the DEA’s ARCOS (Automation of Reports and Consolidated Orders System) data. The disclosure showed that wholesale distributors had shipped 76 billion oxycodone and hydrocodone pills across the United States between 2006 and 2014. The data permitted, for the first time, public county-level and pharmacy-level mapping of the prescription-opioid pipeline. The Mountain State’s saturation was visible at the highest per-capita levels in the dataset, alongside parts of Kentucky, southern Ohio, and southwestern Virginia. See WV opioid crisis overview.

Williamson, WV — 21 Million Hydrocodone Tablets

The single most-cited West Virginia pill-mill data point comes from Williamson, WV — the Mingo County seat in the southern coalfields, on the Tug Fork River across from Pike County, Kentucky. The town’s population at the time was roughly 3,000. Federal prosecutors and HD Media reporters documented that wholesale distributors had shipped approximately 21 million hydrocodone tablets to a single Williamson pharmacy (Sav-Rite Pharmacy) over a roughly 10-year window. The Williamson per-capita pill volume became one of the most widely reproduced facts in the national opioid-crisis literature and a recurring exhibit in Congressional testimony. The U.S. Department of Justice secured guilty pleas and convictions of multiple Williamson-area pharmacists and physicians during the 2009–2015 period.

The Wholesaler Trio — McKesson, Cardinal Health, AmerisourceBergen

Three wholesale distributors handled the great majority of U.S. controlled-substance volume during the pill-mill era:

  • McKesson Corporation — San Francisco, the largest U.S. drug wholesaler
  • Cardinal Health — Dublin, Ohio
  • AmerisourceBergen — Conshohocken, Pennsylvania

The "Big Three" controlled an estimated 85–90% of U.S. drug-distribution market share. Each settled with the federal DEA, with state attorneys general (including West Virginia AG Patrick Morrisey), and ultimately with national class actions in the MDL. The Mountain State recoveries against the Big Three contributed the largest dollar share of West Virginia’s ~$1 billion-plus cumulative opioid-settlement total.

Manufacturers — Purdue, J&J, Endo, Teva, Allergan

The opioid-manufacturer side of the settlement architecture is led by the Purdue Pharma bankruptcy (the Sackler-family-owned manufacturer of OxyContin), the Johnson & Johnson nationwide settlement, and recoveries against Endo Health Solutions, Teva Pharmaceutical Industries, and Allergan. Pharmacy chains Walmart, CVS Health, and Walgreens followed with their own multi-state settlements. The aggregate U.S. opioid-settlement total now exceeds $26 billion, with Purdue’s revised June 2024 settlement (post-Supreme Court decision in Harrington v. Purdue Pharma) adding additional funds to the architecture.

Patrick Morrisey’s WV Recoveries

Then-Attorney General Patrick Morrisey — sworn in as West Virginia AG on January 14, 2013, re-elected in 2016 and 2020, and inaugurated as governor on January 13, 2025 — led West Virginia’s opioid-recovery litigation. The cumulative WV opioid-settlement haul now exceeds $1 billion, the largest per-capita opioid recovery of any state. Specific named WV settlements include:

  • 2017–2019 settlements with McKesson, Cardinal, and AmerisourceBergen totaling several hundred million dollars
  • 2022 multi-state J&J / distributor settlement allocated WV roughly $400 million
  • Endo, Purdue, Teva, Allergan, Walmart, CVS, Walgreens contributions added through 2024

Morrisey’s personal political identity is built on this litigation track record. His 2024 gubernatorial campaign and 2026 governing posture against recreational legalization are explicitly tied to the recovery-culture frame the litigation built. See Gov. Morrisey page.

The West Virginia First Foundation

The bulk of West Virginia’s opioid-settlement proceeds now flow into the West Virginia First Foundation, a quasi-public 501(c)(3) created by the Memorandum of Understanding among the State, the AG’s office, and the state’s 55 county and 230+ municipal governments. The Foundation allocates settlement dollars across prevention, treatment (including MAT), naloxone distribution, recovery housing, criminal-justice diversion, neonatal-abstinence-syndrome care, and workforce development. The Foundation’s board sits in Charleston and operates under West Virginia statutory and AG oversight. The 2024 opioid-mortality inflection (a 46% year-over-year decline) is partially attributed to the operational ramp-up of WV First Foundation–funded harm-reduction and treatment programs. See 2024 inflection page.

Why the Pill-Mill Frame Drives Cannabis Politics

The pill-mill history is the foundational narrative of contemporary West Virginia drug policy. Mountain State legislators, prosecutors, and voters carry direct lived memory of the prescription-opioid wave: a community member, a family member, a coworker lost; a town rebuilt around recovery. That memory cuts in two directions on cannabis policy. Sen. Richard Ojeda’s 2017 SB 386 sponsorship pitched medical cannabis explicitly as a safer alternative to OxyContin and hydrocodone for chronic-pain patients — the opioid frame as argument for medical cannabis. Gov. Patrick Morrisey’s 2024 campaign pitched recreational opposition explicitly as a defense of the recovery culture his litigation built — the opioid frame as argument against recreational legalization. Both framings draw on the same Williamson-21-million-pills history, with opposite policy conclusions. See cannabis-as-alternative page; see Sen. Ojeda page.

Cannabis Reality — The Pill-Mill Numbers

  • 76 billion — oxycodone and hydrocodone pills shipped nationwide 2006–2014 per DEA ARCOS
  • 21 million — hydrocodone tablets to a single Williamson, WV pharmacy over roughly a decade
  • ~3,000 — Williamson’s population at the time of the saturation
  • $26 billion+ — cumulative U.S. opioid-settlement total across distributors, manufacturers, pharmacies
  • $1 billion+ — West Virginia’s share, the largest per-capita state recovery; led by then-AG Morrisey
  • West Virginia First Foundation — the quasi-public entity now channelling Mountain State settlement dollars